Molecular and Cellular Mechanisms Underlying the Initiation and Progression of Alport Glomerular Pathology

Alport syndrome results from a myriad of variants in the COL4A3, COL4A4, or COL4A5 genes that encode type IV (basement membrane) collagens. Unlike type IV collagen alpha 1(IV)(2)alpha 2(IV)(1) heterotrimers, which are ubiquitous in basement membranes, alpha 3/alpha 4/alpha 5 have a limited tissue distribution. The absence of these basement membrane networks causes pathologies in some, but not all these tissues. Primarily the kidney glomerulus, the stria vascularis of the inner ear, the lens, and the retina as well as a rare link with aortic aneurisms. Defects in the glomerular basement membranes results in delayed onset and progressive focal segmental glomerulosclerosis ultimately requiring the patient to undergo dialysis and if accessible, kidney transplant. The lifespan of patients with Alport syndrome is ultimately significantly shortened. This review addresses the consequences of the altered glomerular basement membrane composition in Alport syndrome with specific emphasis on the mechanisms underlying initiation and progression of glomerular pathology.

Automated summary

Alport syndrome is caused by variants in the COL4A3, COL4A4, or COL4A5 genes, resulting in glomerular pathology and other tissue abnormalities. Defects in the glomerular basement membrane lead to progressive glomerulosclerosis, requiring dialysis and kidney transplantation.